首页 > 市场调查报告书 > 医疗设备

生技设备

2030 年欧洲生物分析测试服务市场预测 - 区域分析 - 按服务分类；疾病适应症；和最终用户

市场调查报告书

商品编码

1463676

2030 年欧洲生物分析测试服务市场预测 - 区域分析 - 按服务分类；疾病适应症；和最终用户

Europe Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services ; Disease Indication ; and End User

出版日期: 2024年02月05日 | 出版商:

The Insight Partners | 英文 117 Pages | 订单完成后即时交付

价格

简介目录图表

2022年欧洲生物分析测试服务市值为13.7448亿美元，预计2030年将达到29.5696亿美元；预计2022年至2030年复合CAGR为10.0%。

对生物相似药和生物製剂分析测试的高需求推动了欧洲生物分析测试服务市场

生物製剂是医药市场中最有前景的重要治疗领域之一。发炎性肠道疾病、癌症和类风湿性关节炎等慢性病病例数量的增加推动了对生物製剂的需求。然而，近年来，生物製剂的高成本已将药物开发商和医疗保健利益相关者的注意力转向生物相似药。此外，生物製剂专利和独占期即将到期也为生物相似药的开发创造了机会。据麦肯锡公司称，到2025 年，约有19 种大批量生物製剂将失去排他性。紧随其后。无障碍药物协会 (AAM) 预计，生物相似药推出后，品牌生物製剂的平均价格将下降 25% 左右，因为生物相似药的平均销售价格比原品牌生物製剂低 50% 左右。

生物相似药研发的预期成长将增加对相关生物分析测试服务的需求——生物相似药的兼容性研究、稳定性测试、产品释放测试和生物相似药蛋白质分析——以降低药物开发所涉及的风险。因此，生物相似药分析测试需求的成长正在推动生物分析测试服务市场的成长。

欧洲生物分析测试服务市场概况

欧洲的生物分析测试服务市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。该地区在全球生物分析测试服务市场中占有重要地位。由于製药、生物製药和生物技术行业强大的製造能力，以及欧洲不同国家领先的生物分析测试服务提供商的存在，预计欧洲生物分析测试服务市场在预测期内将显着增长。

欧洲生物分析测试服务市场收入及 2030 年预测（百万美元）

欧洲生物分析测试服务市场细分

欧洲生物分析测试服务市场根据测试类型、疾病适应症、最终用户和国家进行细分。

根据测试类型，欧洲生物分析测试服务市场分为药物动力学、生物标记、免疫原性、病毒学测试、基于细胞的测定等。 2022 年，基于细胞的检测领域占据最大的市场份额。

根据疾病适应症，欧洲生物分析检测服务市场分为心血管、神经系统疾病、代谢性疾病、呼吸道疾病、自体免疫疾病、肿瘤、性健康、骨骼疾病等。 2022 年，肿瘤学领域占据最大的市场。

根据最终用户，欧洲生物分析测试服务市场分为製药和生物製药公司、合约研究组织（CRO）、合约开发和製造组织（CDMO）等。 2022 年，製药和生物製药公司领域占据最大的市场份额。

根据国家/地区，欧洲生物分析测试服务市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。 2022年，德国在欧洲生物分析测试服务市场份额中占据主导地位。

SGS SA、康龙化成北京有限公司、Element Materials Technology Group Ltd、Charles River Laboratories International Inc、Eurofins Scientific SE、Labcorp Drug Development Inc、Syneos Health Inc、KCAS Bioanalytical and Biomarker Services LLC、ICON Plc 和 Intertek Group Plc 等在欧洲生物分析测试服务市场营运的领导公司。

主要市场驱动因素：
- 药厂增加研发活动外包
- 对生物相似药和生物製剂分析测试的高需求
主要市场限制：
- 生物分析方法开发与验证的挑战
主要市场机会
- 医药产业持续成长
未来的趋势
- 针对新兴罕见疾病的药物发现和开发活动不断增加
影响分析：

第 6 章：生物分析测试服务市场 - 欧洲市场分析

生物分析测试服务市场收入，2022 - 2030

第 7 章：欧洲生物分析测试服务市场 - 收入和 2030 年预测 - 按服务分类

概述
2022 年和 2030 年生物分析测试服务市场收入份额（按服务划分）（%）
药物动力学
生物标誌物
免疫原性
病毒学检测
基于细胞的检测
其他的

第 8 章：欧洲生物分析测试服务市场 - 收入和 2030 年预测 - 按疾病适应症

概述
2022 年和 2030 年按疾病适应症分類的生物分析测试服务市场收入份额 (%)
心血管
神经系统疾病
自体免疫疾病
呼吸疾病
代谢紊乱
肿瘤学
性健康
骨病
其他的

第 9 章：欧洲生物分析测试服务市场 - 收入和 2030 年预测 - 按最终用户

概述
2022 年和 2030 年生物分析测试服务市场收入份额（按最终用户划分）（%）
製药和生物製药公司
合约研究组织（CRO）
合约开发与製造组织 (CDMO)
其他的

第 10 章：欧洲生物分析测试服务市场 - 国家分析

德国
英国
法国
义大利
西班牙
欧洲其他地区

第 11 章：生物分析测试服务市场产业格局

概述
生物分析测试服务市场的成长策略
无机成长策略
- 概述
有机成长策略
- 概述

第 12 章：公司简介

SGS SA
Pharmaron Beijing Co Ltd
Element Materials Technology Group Ltd
Charles River Laboratories International Inc
Eurofins Scientific SE
Labcorp Drug Development Inc
Syneos Health Inc
KCAS Bioanalytical and Biomarker Services LLC
ICON Plc
Intertek Group Plc

第 13 章：附录

简介目录图表

Product Code: BMIRE00029558

The Europe bioanalytical testing services market was valued at US$ 1,374.48 million in 2022 and is expected to reach US$ 2,956.96 million by 2030; it is estimated to grow at a CAGR of 10.0% from 2022 to 2030.

High Demand for Analytical Testing of Biosimilars and Biologics Fuel the Europe Bioanalytical Testing Services Market

Biologics are among the most promising therapeutic areas important in the pharmaceutical market. The rising number of cases of chronic diseases such as inflammatory bowel diseases, cancer, and rheumatoid arthritis propels the demand for biologics. However, the high cost of biologics' has redirected the focus of drug developers and healthcare stakeholders toward biosimilars in recent years. Additionally, the imminent expiry of the patents and exclusivity periods of biologics have also created opportunities for the development of biosimilars. According to McKinsey & Co., ~19 high-volume biologics would lose exclusivity by 2025. Additionally, 39 more high-volume biologics are expected to lose patent protection between 2026 and 2032, with more biologics likely to follow. The Association for Accessible Medicines (AAM) expects a ~25% price drop on branded biologics on average after the launch of biosimilars because average biosimilar sales prices are ~50% lower than the original branded biologics.

The anticipated rise in biosimilar R&D would boost the demand for related bioanalytical testing services-compatibility studies for biosimilars, stability testing, product release testing, and biosimilar protein analysis-to reduce the risks involved with medication development. Thus, the rise in demand for analytical testing of biosimilars is boosting the growth of the bioanalytical testing services market.

Europe Bioanalytical Testing Services Market Overview

The bioanalytical testing services market in Europe is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region occupies a significant position in the global bioanalytical testing services market. The European bioanalytical testing services market is expected to witness significant growth during the forecast period due to the strong manufacturing capabilities in the pharmaceutical, biopharmaceutical, and biotechnological industries, and the presence of leading bioanalytical testing service providers in different European countries.

Europe Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Million)

Europe Bioanalytical Testing Services Market Segmentation

The Europe bioanalytical testing services market is segmented based on test type, disease indication, end user, and country.

Based on test type, the Europe bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022.

Based on disease indication, the Europe bioanalytical testing services market is segmented into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held the largest market share in 2022.

Based on end user, the Europe bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2022.

Based on country, the Europe bioanalytical testing services market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe bioanalytical testing services market share in 2022.

SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, KCAS Bioanalytical and Biomarker Services LLC, ICON Plc, and Intertek Group Plc are some of the leading companies operating in the Europe bioanalytical testing services market.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Bioanalytical Testing Services Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Europe PEST Analysis

5. Europe Bioanalytical Testing Services Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
- 5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
5.2 Key Market Restraints:
- 5.2.1 Challenges in Development and Validation of Bioanalytical Methods
5.3 Key Market Opportunities
- 5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
5.4 Future Trends
- 5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
5.5 Impact Analysis:

6. Bioanalytical Testing Services Market - Europe Market Analysis

6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. Europe Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services

7.1 Overview
7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
7.3 Pharmacokinetics
- 7.3.1 Overview
- 7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Biomarkers
- 7.4.1 Overview
- 7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Immunogenicity
- 7.5.1 Overview
- 7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Virology Testing
- 7.6.1 Overview
- 7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.6.2.1 In-Vitro Virology Testing
    - 7.6.2.1.1 Overview
  - 7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 7.6.3 In-Vivo Virology Testing
  - 7.6.3.1 Overview
  - 7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Cell-Based Assays
- 7.7.1 Overview
- 7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication

8.1 Overview
8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
8.3 Cardiovascular
- 8.3.1 Overview
- 8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Neurological Diseases
- 8.4.1 Overview
- 8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Autoimmune Disorders
- 8.5.1 Overview
- 8.5.2 Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Respiratory Diseases
- 8.6.1 Overview
- 8.6.2 Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Metabolic Disorders
- 8.7.1 Overview
- 8.7.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Oncology
- 8.8.1 Overview
- 8.8.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Sexual Health
- 8.9.1 Overview
- 8.9.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.10 Bone Disease
- 8.10.1 Overview
- 8.10.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.11 Others
- 8.11.1 Overview
- 8.11.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Pharmaceutical and Biopharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organization (CRO)
- 9.4.1 Overview
- 9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Development and Manufacturing Organization (CDMO)
- 9.5.1 Overview
- 9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Bioanalytical Testing Services Market - Country Analysis

10.1 Europe Bioanalytical Testing Services Market, Revenue and Forecast to 2030
- 10.1.1 Overview
  - 10.1.1.1 Europe Bioanalytical Testing Services Market by Country
  - 10.1.1.2 Germany
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Germany Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.2.3 Germany Bioanalytical Testing Services Market, by Services
    - 10.1.1.2.3.1 Germany Bioanalytical Testing Services Market, by Virology Testing
    - 10.1.1.2.4 Germany Bioanalytical Testing Services Market, by Disease Indication
    - 10.1.1.2.5 Germany Bioanalytical Testing Services Market, by End User
  - 10.1.1.3 UK
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 UK Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.3.3 UK Bioanalytical Testing Services Market, by Services
    - 10.1.1.3.3.1 UK Bioanalytical Testing Services Market, by Virology Testing
    - 10.1.1.3.4 UK Bioanalytical Testing Services Market, by Disease Indication
    - 10.1.1.3.5 UK Bioanalytical Testing Services Market, by End User
  - 10.1.1.4 France
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 France Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.4.3 France Bioanalytical Testing Services Market, by Services
    - 10.1.1.4.3.1 France Bioanalytical Testing Services Market, by Virology Testing
    - 10.1.1.4.4 France Bioanalytical Testing Services Market, by Disease Indication
    - 10.1.1.4.5 France Bioanalytical Testing Services Market, by End User
  - 10.1.1.5 Italy
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 Italy Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.5.3 Italy Bioanalytical Testing Services Market, by Services
    - 10.1.1.5.3.1 Italy Bioanalytical Testing Services Market, by Virology Testing
    - 10.1.1.5.4 Italy Bioanalytical Testing Services Market, by Disease Indication
    - 10.1.1.5.5 Italy Bioanalytical Testing Services Market, by End User
  - 10.1.1.6 Spain
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Spain Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.6.3 Spain Bioanalytical Testing Services Market, by Services
    - 10.1.1.6.3.1 Spain Bioanalytical Testing Services Market, by Virology Testing
    - 10.1.1.6.4 Spain Bioanalytical Testing Services Market, by Disease Indication
    - 10.1.1.6.5 Spain Bioanalytical Testing Services Market, by End User
  - 10.1.1.7 Rest of Europe
    - 10.1.1.7.1 Overview
    - 10.1.1.7.2 Rest of Europe Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.7.3 Rest of Europe Bioanalytical Testing Services Market, by Services
    - 10.1.1.7.3.1 Rest of Europe Bioanalytical Testing Services Market, by Virology Testing
    - 10.1.1.7.4 Rest of Europe Bioanalytical Testing Services Market, by Disease Indication
    - 10.1.1.7.5 Rest of Europe Bioanalytical Testing Services Market, by End User

11. Bioanalytical Testing Services Market Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Bioanalytical Testing Services Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 SGS SA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Pharmaron Beijing Co Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Element Materials Technology Group Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Eurofins Scientific SE
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Labcorp Drug Development Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Syneos Health Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 KCAS Bioanalytical and Biomarker Services LLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 ICON Plc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Intertek Group Plc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Europe Bioanalytical Testing Services Market Segmentation
Table 2. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
Table 3. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
Table 4. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
Table 5. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 6. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
Table 7. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
Table 8. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
Table 9. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 10. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
Table 11. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
Table 12. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
Table 13. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 14. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
Table 15. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
Table 16. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
Table 17. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 18. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
Table 19. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
Table 20. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
Table 21. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 22. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
Table 23. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
Table 24. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
Table 25. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 26. Recent Inorganic Growth Strategies in the Bioanalytical Testing Services Market
Table 27. Recent Organic Growth Strategies in the Bioanalytical Testing Services Market
Table 28. Glossary of Terms, Europe Bioanalytical Testing Services Market

List Of Figures

Figure 1. Europe Bioanalytical Testing Services Market Segmentation, By Country
Figure 2. Europe - PEST Analysis
Figure 3. Europe Bioanalytical Testing Services Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Europe Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
Figure 7. Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 16. Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
Figure 26. Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Europe Bioanalytical Testing Services Market, By Country, 2022 ($Mn)
Figure 31. Europe Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
Figure 32. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 33. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 34. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 36. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 38. Growth Strategies in the Bioanalytical Testing Services Market